Form 4: Rockwell Medical Director Sells 5,079 Shares

Director John G. Cooper sold 5,079 RMTI shares at $0.87 and now holds 140,372 shares directly.

Summary

• Director John G. Cooper executed an open-market sale (Code S) of 5,079 Rockwell Medical common shares on 11/18/2025 at $0.87 per share.
• Post-transaction, Cooper directly owns 140,372 shares of Rockwell Medical.
• The transaction value is approximately $4,418.73, derived from 5,079 shares at $0.87.
• Ownership is reported as direct; no derivative securities were reported.
• The form was signed by an attorney-in-fact (Megan Timmins) on 11/18/2025.

Sentiment

Score: 4

Explanation: Small open-market insider sale can be a slight negative signal, but the retained stake remains sizable; overall impact appears limited.

Positives

• Insider retains a meaningful stake post-sale: 140,372 shares directly.
• Sale size is modest (~$4.4k), suggesting routine liquidity rather than a substantial reduction.

Negatives

• Insider sale can be perceived as a mild negative signal for near-term sentiment.
• Sale price of $0.87 indicates transactions at a low absolute share price level.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4.

Industry Context

Insider sales of modest size are common across small-cap healthcare and medtech companies and often reflect personal portfolio management rather than a change in company fundamentals.

Comparison to Industry Standards

• The transaction size (~$4.4k) is small relative to typical insider trades seen across small-cap healthcare peers, aligning with routine insider activity.
• Retained ownership (140,372 shares) suggests continued insider alignment, consistent with governance norms at peer companies where directors maintain holdings.
• No 10b5-1 plan indication is provided in the text; absence of a plan is not unusual for small, opportunistic open-market trades.

Stakeholder Impact

• No dilution to shareholders, as this is an open-market sale by an insider.
• May modestly affect investor sentiment due to insider selling, albeit limited by the small size.
• No operational or governance changes indicated for employees, customers, suppliers, or creditors.

Key Dates

Keywords

Rockwell Medical, RMTI, Form 4, insider transaction, insider selling, John G. Cooper, director, common stock, beneficial ownership, open market sale